Alloimmune Versus Autoimmune Hepatitis Following Liver Transplantation

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2022 Jul 28

PMID 35899242

Authors

Claire R Harrington

Josh Levitsky

Affiliations

Soon will be listed here.

Abstract

Content available: Audio Recording.

Citing Articles

Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention.

Mehtani R, Rathi S J Clin Exp Hepatol. 2024; 14(6):101432.

PMID: 38975605 PMC: 11222954. DOI: 10.1016/j.jceh.2024.101432.

Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.

Henson J, King L Clin Liver Dis. 2023; 28(1):193-207.

PMID: 37945160 PMC: 11033708. DOI: 10.1016/j.cld.2023.07.009.

Alloimmune versus autoimmune hepatitis following liver transplantation.

Harrington C, Levitsky J Clin Liver Dis (Hoboken). 2022; 20(1):21-24.

PMID: 35899242 PMC: 9306487. DOI: 10.1002/cld.1234.

References

Chan C, Schiano T, Agudelo E, Haydek J, Hoteit M, Laurito M . Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy. Am J Transplant. 2018; 18(10):2506-2512. DOI: 10.1111/ajt.15053. View

Reich D, Fiel I, Guarrera J, Emre S, Guy S, Schwartz M . Liver transplantation for autoimmune hepatitis. Hepatology. 2000; 32(4 Pt 1):693-700. DOI: 10.1053/jhep.2000.16666. View

Abbas K, Mubarak M, Zafar M, Musharraf W, Imam M, Aziz T . Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor. Exp Clin Transplant. 2018; 17(1):42-46. DOI: 10.6002/ect.2017.0154. View

Harrington C, Levitsky J . Alloimmune versus autoimmune hepatitis following liver transplantation. Clin Liver Dis (Hoboken). 2022; 20(1):21-24. PMC: 9306487. DOI: 10.1002/cld.1234. View

Mack C, Adams D, Assis D, Kerkar N, Manns M, Mayo M . Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2019; 72(2):671-722. DOI: 10.1002/hep.31065. View

Kerkar N, Dugan C, Rumbo C, Morotti R, Gondolesi G, Shneider B . Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant. 2005; 5(5):1085-9. DOI: 10.1111/j.1600-6143.2005.00801.x. View

Demetris A, Bellamy C, Hubscher S, OLeary J, Randhawa P, Feng S . 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016; 16(10):2816-2835. DOI: 10.1111/ajt.13909. View

Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S . Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation. 2004; 78(1):128-35. DOI: 10.1097/01.tp.0000132328.33460.43. View

Levitsky J, Fiel M, Norvell J, Wang E, Watt K, Curry M . Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012; 142(5):1132-1139.e1. DOI: 10.1053/j.gastro.2012.01.030. View

10.

Fiel M, Agarwal K, Stanca C, Elhajj N, Kontorinis N, Thung S . Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl. 2008; 14(6):861-71. DOI: 10.1002/lt.21447. View

11.

Aguilera I, Sousa J, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A . Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl. 2004; 10(9):1166-72. DOI: 10.1002/lt.20209. View